News By Tag
News By Location
Investigational Drug Service Software, Vestigo®, Selected by Henry Ford Health System
McCreadie Group Welcomes Their Second Michigan Vestigo Client, the Henry Ford Health System, a Major Leader in Clinical Research
Henry Ford Health System is a premier academic medical center focusing on teaching, research and advanced patient care. Currently, leading-edge researchers are engaged in over 1,800 ongoing clinical research projects. "The Henry Ford Health System has earned a national reputation for their exceptional clinical trials," said Mike Schlesselman, PharmD, director of research products for McCreadie Group. "We are proud that they have chosen Vestigo to assist with increasing IDS compliance, efficiency and safety."
Launched in 2005, Vestigo eliminates many of the manual steps involved in investigational drug service operations. It has set the industry standard for IDS automation by significantly enhancing efficiencies while helping ensure that complex protocols are properly managed for consistency, safety and compliance.
Vestigo adds accuracy and efficiencies to protocol management, inventory control, dispensing and labeling, billing, accountability reporting, monitoring activities and scheduling. It also facilitates compliance to the principles and best practices of IDS, including the Hematology/Oncology Pharmacy Association (HOPA) Best Practice Standards, which apply to any clinical research involving medications.
About The McCreadie Group
McCreadie Group, Inc. was founded in 2004 to provide software solutions for pharmacy applications in healthcare, research and educational settings. The company's goal is to drive improvements in quality, efficiency, safety and compliance in the pharmacy profession by delivering innovative software and consultative support to healthcare providers, researchers and stakeholders in pharmacy education. To learn more about McCreadie Group and its products, visit http://www.mccreadiegroup.com.
# # # #
The McCreadie Group